Karen Woo1, Jesus Ulloa2, Michael Allon3, Christopher G Carsten4, Eric S Chemla5, Mitchell L Henry6, Thomas S Huber7, Jeffrey H Lawson8, Charmaine E Lok9, Eric K Peden10, Larry Scher11, Anton Sidawy12, Melinda Maggard-Gibbons13, David Cull4. 1. Division of Vascular Surgery, David Geffen School of Medicine, University of California, Los Angeles, Calif. Electronic address: kwoo@mednet.ucla.edu. 2. Department of Surgery, UCSF School of Medicine, University of California, San Francisco, Calif. 3. Division of Nephrology, University of Alabama School of Medicine, University of Alabama, Birmingham, Ala. 4. Division of Vascular Surgery, University of South Carolina School of Medicine, University of South Carolina, Greenville, SC. 5. St. George's University Hospitals NHS Foundation Trust Vascular Institute, St. George's University, London, United Kingdom. 6. Division of Transplantation Surgery, The Ohio State University College of Medicine, The Ohio State University, Columbus, Ohio. 7. Division of Vascular Surgery, University of Florida College of Medicine, University of Florida, Gainesville, Fla. 8. Division of Vascular Surgery, Duke University School of Medicine, Duke University, Durham, NC. 9. Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 10. Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, Tex. 11. Department of Cardiothoracic and Vascular Surgery, Albert Einstein College of Medicine, Bronx, NY. 12. Division of Vascular Surgery, George Washington School of Medicine and Health Sciences, George Washington University, Washington, D.C. 13. Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Calif.
Abstract
OBJECTIVE: The Kidney Disease Outcome Quality Initiative and Fistula First Breakthrough Initiative call for the indiscriminate creation of arteriovenous fistulas (AVFs) over arteriovenous grafts (AVGs) without providing patient-specific criteria for vascular access selection. Although the U.S. AVF rate has increased dramatically, several reports have found that this singular focus on increasing AVFs has resulted in increased AVF nonmaturation/early failure and a high prevalence of catheter dependence. The objective of this study was to determine the appropriateness of vascular access procedures in clinical scenarios constructed with combinations of relevant factors potentially influencing outcomes. METHODS: The RAND/UCLA Appropriateness Method was used. Accordingly, a comprehensive literature search was performed and a synthesis of results compiled. The RAND/UCLA Appropriateness Method was applied to 2088 AVF and 1728 AVG clinical scenarios with varying patient characteristics. Eleven international vascular access experts rated the appropriateness of each scenario in two rounds. On the basis of the distribution of the panelists' scores, each scenario was determined to be appropriate, inappropriate, or indeterminate. RESULTS: Panelists achieved agreement in 2964 (77.7%) scenarios; 860 (41%) AVF and 588 (34%) AVG scenarios were scored appropriate, 686 (33%) AVF and 480 (28%) AVG scenarios were scored inappropriate, and 542 (26%) AVF and 660 (38%) AVG scenarios were indeterminate. Younger age, larger outflow vein diameter, normal or obese body mass index (vs morbidly obese), larger inflow artery diameter, and higher patient functional status were associated with appropriateness of AVF creation. Older age, dialysis dependence, and smaller vein size were associated with appropriateness of AVG creation. Gender, diabetes, and coronary artery disease were not associated with AVF or AVG appropriateness. Dialysis status was not associated with AVF appropriateness. Body mass index and functional status were not associated with AVG appropriateness. To simulate the surgeon's decision-making, scenarios were combined to create situations with the same patient characteristics and both AVF and AVG options for access. Of these 864 clinical situations, 311 (36%) were rated appropriate for AVG but inappropriate or indeterminate for AVF. CONCLUSIONS: The results of this study indicate that patient-specific situations exist wherein AVG is as appropriate as or more appropriate than AVF. These results provide patient-specific recommendations for clinicians to optimize vascular access selection criteria, to standardize care, and to inform payers and policy. Indeterminate scenarios will guide future research. Published by Elsevier Inc.
OBJECTIVE: The Kidney Disease Outcome Quality Initiative and Fistula First Breakthrough Initiative call for the indiscriminate creation of arteriovenous fistulas (AVFs) over arteriovenous grafts (AVGs) without providing patient-specific criteria for vascular access selection. Although the U.S. AVF rate has increased dramatically, several reports have found that this singular focus on increasing AVFs has resulted in increased AVF nonmaturation/early failure and a high prevalence of catheter dependence. The objective of this study was to determine the appropriateness of vascular access procedures in clinical scenarios constructed with combinations of relevant factors potentially influencing outcomes. METHODS: The RAND/UCLA Appropriateness Method was used. Accordingly, a comprehensive literature search was performed and a synthesis of results compiled. The RAND/UCLA Appropriateness Method was applied to 2088 AVF and 1728 AVG clinical scenarios with varying patient characteristics. Eleven international vascular access experts rated the appropriateness of each scenario in two rounds. On the basis of the distribution of the panelists' scores, each scenario was determined to be appropriate, inappropriate, or indeterminate. RESULTS: Panelists achieved agreement in 2964 (77.7%) scenarios; 860 (41%) AVF and 588 (34%) AVG scenarios were scored appropriate, 686 (33%) AVF and 480 (28%) AVG scenarios were scored inappropriate, and 542 (26%) AVF and 660 (38%) AVG scenarios were indeterminate. Younger age, larger outflow vein diameter, normal or obese body mass index (vs morbidly obese), larger inflow artery diameter, and higher patient functional status were associated with appropriateness of AVF creation. Older age, dialysis dependence, and smaller vein size were associated with appropriateness of AVG creation. Gender, diabetes, and coronary artery disease were not associated with AVF or AVG appropriateness. Dialysis status was not associated with AVF appropriateness. Body mass index and functional status were not associated with AVG appropriateness. To simulate the surgeon's decision-making, scenarios were combined to create situations with the same patient characteristics and both AVF and AVG options for access. Of these 864 clinical situations, 311 (36%) were rated appropriate for AVG but inappropriate or indeterminate for AVF. CONCLUSIONS: The results of this study indicate that patient-specific situations exist wherein AVG is as appropriate as or more appropriate than AVF. These results provide patient-specific recommendations for clinicians to optimize vascular access selection criteria, to standardize care, and to inform payers and policy. Indeterminate scenarios will guide future research. Published by Elsevier Inc.
Authors: A M O'Hare; D Bertenthal; L C Walter; A X Garg; K Covinsky; J S Kaufman; R A Rodriguez; M Allon Journal: Kidney Int Date: 2007-01-24 Impact factor: 10.612
Authors: H Hemingway; A M Crook; J R Dawson; J Edelman; S Edmondson; G Feder; P Kopelman; E Leatham; P Magee; L Parsons; A D Timmis; A Wood Journal: J Public Health Med Date: 1999-12
Authors: Lannery S Lauvao; Daniel M Ihnat; Kaoru R Goshima; LeAnn Chavez; Angelika C Gruessner; Joseph L Mills Journal: J Vasc Surg Date: 2009-06 Impact factor: 4.268
Authors: Irina Yermilov; Marcia L McGory; Paul W Shekelle; Clifford Y Ko; Melinda A Maggard Journal: Obesity (Silver Spring) Date: 2009-04-02 Impact factor: 5.002
Authors: Ivan D Maya; Jeremy C O'Neal; Carlton J Young; Jill Barker-Finkel; Michael Allon Journal: Clin J Am Soc Nephrol Date: 2008-10-22 Impact factor: 8.237
Authors: Anton N Sidawy; Lawrence M Spergel; Anatole Besarab; Michael Allon; William C Jennings; Frank T Padberg; M Hassan Murad; Victor M Montori; Ann M O'Hare; Keith D Calligaro; Robyn A Macsata; Alan B Lumsden; Enrico Ascher Journal: J Vasc Surg Date: 2008-11 Impact factor: 4.268
Authors: Yong Pey See; Yeoungjee Cho; Elaine M Pascoe; Alan Cass; Ashley Irish; David Voss; Kevan R Polkinghorne; Lai Seong Hooi; Loke-Meng Ong; Peta-Anne Paul-Brent; Peter G Kerr; Trevor A Mori; Carmel M Hawley; David W Johnson; Andrea K Viecelli Journal: Kidney360 Date: 2020-09-14
Authors: David B Kingsmore; Karen S Stevenson; S Richarz; Andrej Isaak; Andrew Jackson; Ram Kasthuri; Peter C Thomson Journal: Sci Rep Date: 2021-05-24 Impact factor: 4.379
Authors: Alexandru Oprea; Adrian Molnar; Dan Vlăduţiu; Traian Scridon; Cătălin Trifan; Diana Săcui; Vasile Săsărman; Petru Adrian Mircea Journal: Clujul Med Date: 2018-10-30